LATEST KEY DEVELOPMENTS
Competition & State Aid
• Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing
• European Parliament issues Study on Non-performing Loans (“NPLs”), including addressing EU State aid rules and potential surge in NPLs due to COVID-19 crisis
• EU approves new and amended Member State measures to support the economy
Trade / Export Controls
• European Commission extends export authorization mechanism for COVID-19 vaccines until 30 June 2021
• European Parliament INTA Committee meeting to discuss COVID-19 related topics
Medicines and Medical Devices
• EMA to review administration of AstraZeneca’s COVID-19 vaccine and potential related thromboembolic events
• European Commission grants conditional marketing authorization to Janssen’s single-dose COVID-19 vaccine
• EMA starts rolling review of Eli Lilly antibodies for treatment of COVID-19
Cybersecurity, Privacy & Data Protection
• European Commission issues Outline on a Trust Framework for Interoperability of health certificates
Please see full publication below for more information.